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Abstract
Adrenomedullin (AM) and its receptor complexes, calcitonin receptor-like receptor (Calcrl) and receptor activity modifying
protein 2/3, are highly expressed in lymphatic endothelial cells and are required for embryonic lymphatic development. To
determine the role of Calcrl in adulthood, we used an inducible Cre-loxP system to temporally and ubiquitously delete Calcrl
in adult mice. Following tamoxifen injection, Calcrlfl/fl/CAGGCre-ERTM mice rapidly developed corneal edema and
inflammation that was preceded by and persistently associated with dilated corneoscleral lymphatics. Lacteals and
submucosal lymphatic capillaries of the intestine were also dilated, while mesenteric collecting lymphatics failed to properly
transport chyle after an acute Western Diet, culminating in chronic failure of Calcrlfl/fl/CAGGCre-ERTM mice to gain weight.
Dermal lymphatic capillaries were also dilated and chronic edema challenge confirmed significant and prolonged dermal
lymphatic insufficiency. In vivo and in vitro imaging of lymphatics with either genetic or pharmacologic inhibition of AM
signaling revealed markedly disorganized lymphatic junctional proteins ZO-1 and VE-cadherin. The maintenance of AM
signaling during adulthood is required for preserving normal lymphatic permeability and function. Collectively, these
studies reveal a spectrum of lymphatic defects in adult Calcrlfl/fl/CAGGCre-ERTM mice that closely recapitulate the clinical
symptoms of patients with corneal, intestinal and peripheral lymphangiectasia.
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Introduction
The lymphatic vascular system is a complex vascular network
that permeates nearly every organ of the body and plays a critical
role in the maintenance of fluid homeostasis, the absorption of
intestinal lipids and the trafficking and maturation of immune cells
[1]. Despite its pervasive functions, it is surprising that very little is
known about the genetic and molecular pathways that regulate
lymphatic vascular function in adults [2]. Fortunately, the past
dozen years has provided a relative explosion of new and
sometimes unexpected genes involved in the development of the
lymphatic vascular system, based largely on elegant and exciting
embryonic phenotypes uncovered in gene knockout studies in mice
and in vertebrate model organisms like zebrafish and xenopus [3].
Some of these discoveries have even paved the way toward the
identification and better understanding of human genes in which
mutations are causally associated with congenital, primary
lymphedema such as FOXC2, FLT4, SOX18, GJC2 and CCBE1.
Nevertheless, the development of additional genetic mouse models
of lymphatic insufficiency during adulthood is still needed in order
to identify novel candidate genes either for genetic testing in
families with congenital forms of lymphedema or for therapeutic
targeting of lymphatics in disease.
Failure of lymphatic vessels to function properly in adults can
result in numerous types of clinical conditions, including primary
and secondary lymphedema, which can have a broad range of
clinical presentations and associated correlates [4,5]. Some
congenital forms of primary lymphedema are associated with
lymphangiectasia, which is typically characterized as dilation and
enlargement of lymphatic vessels. Interestingly, there are a few
organ systems, including the intestine [6], the conjunctiva of the
eye [7] and the dermis [8], that are particularly prone to
developing lymphangiectasia. While the pathophysiological mech-
anisms leading to lymphangiectasia are not well understood, it is
likely that dilated lymphatic vessels are the result of lymphatic
obstruction and improper drainage or lymph stasis. The conse-
quences of persistent lymphangiectasia include, on a cellular level,
increased permeability of dilated lymphatic vascular beds, and on
a systemic level, protein-losing enteropathy, limb lymphedema and
ocular irritation with dryness. Although lymphangiectasia can be
associated with a variety primary, congenital lymphedema
syndromes, there is currently no known genetic pathway that
directly and predominantly contributes to lymphangiectasia.
Using gene targeting approaches in mice, we have previously
discovered and characterized an essential role for adrenomedullin
(gene = Adm, peptide = AM) peptide and its receptor complex in
lymphatic vascular development. Adrenomedullin, a secreted,
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multi-functional peptide that is highly expressed in endothelial
cells, binds and signals through a G protein-coupled receptor,
calcitonin receptor-like receptor (gene = Calcrl; protein = CLR), when the
receptor is associated with receptor activity modifying proteins 2
or 3 (RAMP2/3). The complex formed by CLR and RAMP2 is
referred to as the adrenomedullin 1 (AM1) receptor, while the
CLR and RAMP3 complex is referred to as the AM2 receptor;
both of which bind AM peptide, but differ in their relative binding
affinities [9]. Gene knockout mice for Adm [10], Calcrl [11], and
Ramp2 [12,13] all exhibit mid-gestational embryonic lethality
characterized by hydrops fetalis, or marked edema, that is
associated with arrested lymphatic vascular development. Condi-
tional deletion of Calcrl in endothelial cells confirmed that AM
signaling, and its downstream activation of the MAPK/ERK
signaling cascade, is required for normal lymphatic endothelial cell
proliferation during development.
AM signaling through Calcrl/Ramp2 also has robust effects on
endothelial cell permeability. For example, AM can abrogate the
permeabilizing effects of hydrogen peroxide and thrombin on
human umbilical vein endothelial cells [14] and it can retard the
transport of molecules across the blood brain barrier by tightening
the permeability of cerebral endothelial cells [15,16]. Similarly, we
have shown that AM can impact the permeability and function of
lymphatic endothelial cells (LECs). Treatment of cultured LECs
with AM significantly and functionally reduced their permeability
by causing a subcellular reorganization of the junctional proteins
ZO-1 and VE-Cadherin [17]. Furthermore, in vivo tail micro-
lymphography reinforced these findings since mice injected with
AM showed reduced lymph velocity through dermal lymphatic
capillaries, indicative of functionally reduced permeability [17].
The apparently biased effects of AM signaling on the embryonic
development of lymphatic vessels, versus blood vessels, is likely
attributable to the increased expression of Calcrl and Ramp2 in
LECs, compared to blood endothelial cells [18–20]. Consistent
with this notion, continuous administration of AM promoted
lymphangiogenesis and ameliorated secondary tail lymphedema in
a surgical injury mouse model [21]. Whether the maintained
expression of Calcrl in adult animals is also required for
appropriate lymphatic function remains unclear. To address this
question, we used a ubiquitously expressed, tamoxifen-inducible
Cre transgenic mouse line (CAGGCre-ERTM) to delete a floxed
Calcrl gene in 3–4 month old animals and thus explore the role of
Calcrl during adulthood. Our results continue to support a
preferential role for Calcrl in the lymphatic vasculature and reveal
that Calcrl expression in adult animals is critical for maintaining




Mice used in these studies were generated from crossing Calcrlfl/fl
[12] mice (N7-10 on C57BL/6 background) to CAGGCre-ERTM
mice [The Jackson Laboratory, Bar Harbor, ME 004682, B6.Cg-
Tg(CAG-cre/Esr1)5Amc/J]. Male and female adult mice aged 3–4
months were administered tamoxifen (Sigma) consecutively for 5
days (5 mg/40 g body weight; IP). Mice were genotyped for the
floxed and Cre alleles as well as the excised allele after tamoxifen
injection. Primer sets (59-39) P1: gcggagcatattcaatcacaag, P2:
gaaatgtgctgtatgttcaagc, P3: gacgagttcttctgagggga, and P4: gaataagtt-
gagctgggcag were used (P1/P2 for wildtype allele; P1/P3 for floxed
allele; P1/P4 for excised allele). Mice were routinely anesthetized
using 0.2–0.4 ml/10 g body weight of avertin (2,2,2,-Tribromo-
ethanol, 20 mg/ml, Sigma).
For Western Diet studies, mice were fed Teklad Adjusted
Calories Diet (TD.88137; 42% from fat; Harlan Laboratories) for
1K weeks and then housed in metabolic cages for 24 hours during
which food intake, urine, and fecal samples were measured.
Weights of mice were also recorded before tamoxifen injection,
after tamoxifen injection, and after Western Diet.
All experimental procedures involving mice were approved by
the Institutional Animal Care and Use Committee of The
University of North Carolina Chapel Hill and all efforts were
made to minimize suffering.
Cell Culture
Human adult dermal lymphatic endothelial cells (HMVEC-
dLyAd-Der Lym Endo Cells, Lonza) of 8 passages or less were
maintained using EGM-2MV media with bullet kit (Lonza). Cells
were seeded in 6 well plates at 100,000 cells/well and grown on
acid washed coverslips until monolayers formed. Treatment
conditions included no treatment (control), 10 nM AM (American
Peptide Co.,Inc.), 1 mM AM22-52 (AM antagonist; American
Peptide Co.,Inc.) or AM+AM22-52. Cells were treated for 15
minutes and in the condition with AM+AM22-52, cells were pre-
treated with AM22-52 for 30 minutes. Cells were rinsed with
HBSS, fixed with 1% PFA, rinsed 365 minutes with PBS, and
then blocked for 20 minutes with 2% normal donkey serum/0.1%
Triton X in PBS. The cells were then incubated overnight at room
temperature with primary antibodies (VE-Cadherin = 1:200, goat
polyclonal; sc-6458, Santa Cruz Biotechnology, Santa Cruz, CA;
ZO-1 = 1:200, monoclonal rat a mouse; clone R40.76, Millipore,
Billerica, MA), rinsed 365 minutes with PBS, blocked with 2%
normal donkey serum (NDS) for 10 minutes, followed by
incubation with secondary antibody for 1 hour at room
temperature, rinsed 365 minutes with PBS and then mounted
on slides using Mowiol.
Immunohistochemistry and Immunofluorescence
Tissues were dissected, fixed with 4% PFA overnight and
embedded in paraffin or protected in 30% sucrose and embedded
in OCT (Tissue-Tek) for sectioning. Sections were permeabilized
using 0.1% Triton X-100 (in 0.01 M PBS; pH 7.2; 15 minutes),
blocked with 5% NDS (in 0.1% Triton X-100; 30 minutes),
incubated overnight in primary antibodies, PBS rinsed (365 min-
utes), blocked with 5% NDS (30 minutes), incubated with
secondary antibodies (2 hours), rinsed with PBS and coverslipped
with Mowiol. Primary antibodies included: LYVE-1 (1:200;
polyclonal rabbit a mouse; Fitzgerald, Acton, MA), podoplanin
(1:200, Syrian hamster a mouse, Developmental Studies Hybrid-
oma Bank, Univ. Iowa), ZO-1 (1:200, monoclonal rat a mouse;
clone R40.76, Millipore, Billerica, MA) and VE-Cadherin (1:200,
goat polyclonal; sc-6458, Santa Cruz Biotechnology, Santa Cruz,
CA). Secondary antibodies included Alexa Fluor 594, Alexa Fluor
488 and Cy3 (1:200, Jackson Immunoresearch) and nuclear
marker DAPI (1:1000, bisbenzimide 33258; Sigma, St. Louis,
MO). TUNEL staining was performed using the ApopTag
Fluorescein In Situ Apoptosis Detection Kit (S7110, Chemicon
International) according to the manufacturer’s protocol.
Tonometry
Tonometry was performed in anesthetized adult mice using a
TonoLab tonometer (Colonial Medical Supply) as described
previously [22,23]. After avertin injection, a drop of tetracaine
hydrochloride 0.5% (Alcon) was placed on the eye as a local
anesthetic. Eyes were lubricated throughout testing with TEARS
Naturale FORTE (Alcon). At least six readings were recorded per
eye and averaged.
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Tail Microlymphography and Vessel Diameter
Three to four months post tamoxifen injection, adult mice were
used for tail microlymphography as described previously [17] with
several modifications. FITC-conjugated dextran (200 kDa; 1 ml;
Molecular Probes, Invitrogen Detection Technologies) was inject-
ed intradermally into the mouse tail using a 5 ml Hamilton syringe
fitted with a 30 gauge needle. Images were taken every minute for
15 minutes and image analysis was performed using Adobe
Photoshop 7.0 and Image J.
Lymphatic and Blood Permeability Assays
An ear lymphatic permeability assay was performed as
previously described [24] with minor modification. Ears of
anesthetized mice were injected intradermally with 2 ml of 0.5%
Evan’s Blue dye (in saline) with a 10 ul Hamilton syringe. Images
were taken immediately after injection and 5 minutes after
injection. A blood permeability assay was performed as previously
described with slight modifications to the protocol [25]. Anesthe-
tized mice were retro-orbitally injected with 200 ml 0.5% Evan’s
Blue dye (in saline). After 30 minutes, the mice were perfused with
saline and the liver, lung, adductor muscle, spleen, intestine, heart,
and brain were harvested. Tissues were weighed and desiccated
overnight at 55uC followed by formamide extraction (55uC,
overnight) and 100 ml was used for absorbance reading at 600 nm.
Acid Steatocrit/Lipase/Triglyceride Measurements
Fecal samples collected after Western Diet were examined by
testing for fecal steatocrit and fecal lipase as previously described
[26] with recent modifications [27]. Fecal specimens were
powdered and mixed with 1N perchloric acid and 0.5% oil red
O and placed in a capillary tube and centrifuged. Steatocrit was
calculated as 100 6 [length of fatty layer/(length of solid
layer+length of fatty layer)]. Fecal lipase and serum triglycerides
were analyzed at the Animal Clinical Chemistry and Gene
Expression Labs (UNC-CH).
Dot Blot Assay
A dot blot assay using digested fecal samples was performed as
previously described [28] with slight modification. In short, mice
were fed Western Diet for 1K weeks and fecal samples were
collected and stored at 220uC. TBS with 5% nonfat dry milk (with
protease inhibitors) was added to the fecal samples (20 ml/mg).
The samples were vortexed and sonicated then centrifuged at
16,000 g for 10 minutes after which the supernatant was collected.
Three microliters of each supernatant (1:2000 dilution) was dotted
onto a nitrocellulose membrane. The membrane was blocked
(TBS+3% nonfat dry milk) for 2 hours at room temperature,
rinsed with TBST (165 minutes), then incubated overnight with
primary antibody (mouse anti alpha-1 antitrypsin-1:500; Novus
and mouse anti-actin-1:10000; Sigma) in TBST+3% nonfat dry
milk at 4uC. The membrane was rinsed with TBST (3610
minutes), incubated with secondary antibody in TBST (HRP goat
anti-mouse; 1:2000; Upstate) for 45 minutes at room temperature
followed by TBST (365 minutes) rinses and a final TBS (165
minutes) rinse. The membrane was then developed with film
(GeneMate) using WesternBright ECL reagents (Advansta).
Analysis of integrated density was performed using Image J.
Edema Formation Assay
Anesthetized mice were injected with 10 ml of 4 mg/ml
Complete Freund’s Adjuvant (CFA) in one hind paw. The other
hind paw served as an internal control. Paw thickness was
measured with calipers before injection of CFA and every other
day after injection up to 21 days.
RNA and qRT-PCR
Lung and heart tissue were collected in RNAlater Solution
(Ambion). RNA was extracted from tissue using TRIZOL
(Ambion, Life Technologies) isolation followed by DNAse
treatment (Promega) and cDNA preparation. Quantative RT-
PCR was performed on a Stratagene Mx-3000p machine (La Jolla,
CA) using TAQMAN GEx Master Mix (Applied Biosystems).
Calcrl expression was assessed using Assay-on-Demand for Calcrl
(Mm00516986_m1; Applied Biosystems). The comparative quan-
titation (DDCT) method was used to determine the relative level of
Calcrl expression in the tissues compared to mouse embryo total
RNA calibrator (Ambion). All assays were repeated at least three
times and run in duplicate.
Statistical Analysis
All experiments were repeated at least 3 times and data are
expressed as means with SEM values. Student t tests (tails = 2,
type = 3) and two-way ANOVA were performed and P#0.05 was
considered significant.
Results
Temporal Deletion of Calcrl Results in Acute Onset Eye
Phenotype with Enlarged Corneoscleral Lymphatic
Vessels
Tamoxifen injection resulted in a significant reduction of Calcrl
gene expression in Calcrlfl/fl/CAGGCre-ERTM animals compared to
Calcrlfl/fl animals and to Calcrlfl/fl/CAGGCre-ERTM non-injected
animals (control animals) as indicated by qRT-PCR of lung and
heart tissue (Figure S2). Within 7 to 10 days of tamoxifen injection,
the majority of Calcrlfl/fl/CAGGCre-ERTM mice, but none of the
control Calcrlfl/fl tamoxifen-injected mice, developed distinct
graying of their eyes and the surface of their corneas appeared
rough and coarse (Figure 1A,B). The rapid onset of this phenotype
prompted us to determine whether it was associated with
glaucoma, since a previous study by Ittner et al. indicated that
overexpression of Calcrl in smooth muscle of mice resulted in a
phenotype similar to glaucoma [29]. To this end, TUNEL staining
indicated no difference in retinal ganglion cell death between
Calcrlfl/fl/CAGGCre-ERTM and Calcrlfl/fl control mice (Figure S1A
and S1B). We also found no significant histological differences in
the optic nerve of Calcrlfl/fl/CAGGCre-ERTM mice compared to
Calcrlfl/fl control mice (data not shown). Finally, we found no
significant difference in the intraocular pressure of Calcrlfl/fl/
CAGGCre-ERTM and Calcrlfl/fl control mice when compared either
before injection or after injection of tamoxifen (Figure S1C) and all
intraocular pressure measurements were within the normal range
for C56BL/6 mice [22]. Taken together, these data rule out the
possibility that the acute-onset eye phenotype in Calcrlfl/fl/
CAGGCre-ERTM mice is associated with classical features of
glaucoma.
However, hematoxylin and eosin staining of eyes revealed
marked changes in histology of the Calcrlfl/fl/CAGGCre-ERTM
corneas relative to those of Calcrlfl/fl control mice. The corneas of
Calcrlfl/fl/CAGGCre-ERTM mice were thickened and edematous and
often showed a disrupted and damaged epithelial lining (Figure 1
C,D, arrow). We also observed pronounced inflammation in the
anterior chamber and cornea of Calcrlfl/fl/CAGGCre-ERTM mice
(Figure 1E,F, arrowhead).
Based on the well-established role of Calcrl in lymphatic vascular
development [12], the edema and inflammation in the corneas of
Temporal Loss of Calcitonin Receptor-Like Receptor
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Calcrlfl/fl/CAGGCre-ERTM mice suggested to us that there may be
problems with the lymphatic vessels of the eyes, particularly those
within the corneoscleral junction, which is analogous to the
conjunctival lymphatics in humans. Specifically, we found
podoplanin-positive and LYVE-1-positive staining in the ciliary
body and in vessels at the corneoscleral junction (Figure 1G,H,
arrow). Interestingly, the lymphatic vessels at the corneoscleral
junction of Calcrlfl/fl/CAGGCre-ERTM mice were significantly
dilated and twice the size of corneoscleral lymphatics in Calcrlfl/fl
control mice (Figure 1I,J,K), similar to the phenotype observed in
humans with conjunctival lymphangiectasia. More importantly,
the eyes of Calcrlfl/fl/CAGGCre-ERTM mice that did not present
with the overt corneal pathology (approximately 1/3rd of the
mice), either because they failed to develop the phenotype or they
were euthanized prior to the onset of the phenotype, still showed
significantly dilated lymphatics at the corneoscleral junction.
Taken together, these data demonstrate that an abnormal
lymphatic vessel phenotype precedes the onset of acute corneal
pathology in Calcrlfl/fl/CAGGCre-ERTM mice.
Calcrlfl/fl/CAGGCre-ERTM Mice Exhibit Enlarged
Submucosal Lymphatic Vessels and Lacteals in the
Intestine with Dysfunctional Mesenteric Collecting
Lymphatic Vessels
Since dilated lymphatic vessels were observed at the corneo-
scleral junction in the Calcrlfl/fl/CAGGCre-ERTM mice, we wanted
to assess the morphology and function of lymphatic vessels in other
lymphatic vascular beds, for example, within the intestine. The
overall histology of the intestines of Calcrlfl/fl/CAGGCre-ERTM mice
was normal when compared to that of Calcrlfl/fl control mice under
normal conditions (Figure 2A,B). Lymphatic vessels within the
intestine were identified with LYVE-1 and podoplanin staining,
showing co-localization within the lacteals and the submucosal
lymphatics (Figure 2C–E). Interestingly, the submucosal lymphat-
ics and lacteals of the jejunum were also markedly dilated in the
Calcrlfl/fl/CAGGCre-ERTM mice (Figure 2F,G), as evidenced by the
visibly larger diameter of the submucosal lymphatics and a greater
proportion of villi sections revealing enlarged, LYVE-1-positive
lacteals. Once again, these dilated lymphatics vessels are
Figure 1. Acute-onset eye phenotype, eye inflammation,
edema, and enlarged lymphatic vessels in Calcrlfl/fl/CAGGCre-
ERTM mice. A,B, Gross eye images indicating normal appearance of the
control Calcrlfl/fl mice (A) and the distinct color change and disruption of
the cornea of Calcrlfl/fl/CAGGCre-ERTM (B), (scale = 2 mm). C,D, Hema-
toxylin and eosin staining of mouse eyes indicating normal histology in
Calcrlfl/fl (C) and disruption of the cornea in Calcrlfl/fl/CAGG-CreERTM mice
(D), (4x objective,scale = 500 mm). E,F, Higher magnification of histo-
logical sections of eyes from Calcrlflf/fl mice (E) as compared to Calcrlfl/fl/
CAGGCre-ERTM mice (F) exhibiting corneal edema (arrow) and inflam-
mation (arrowhead) (10x objective, scale = 200 mm). Gross anatomy and
histology images are representative from Calcrlflf/fl mice (n = 8) and
Calcrlfl/fl/CAGGCre-ERTM mice (n = 9). G, Eye diagram indicating the
location of components of the eye (l = lens, c = cornea, ac = anterior
chamber, cb = ciliary body, i = iris). H, Lymphatic markers expressed in
the eye shown by podoplanin(red) and Lyve-1(green) staining in a
control mouse eye (20x objective, scale = 100 mm). I,J, Visualization of
lymphatic vessels at the corneoscleral junction in the Calcrlflf/fl (I) and
Calcrlfl/fl/CAGGCre-ERTM mice (J) indicating enlarged lymphatic vessels in
Calcrlfl/fl/CAGGCre-ERTM mice (Lyve-1 = green; DAPI = blue; 20x objective,
scale = 100 mm). K, Graph representing increased lymphatic vessel area
at the corneoscleral junction in Calcrlfl/fl/CAGGCre-ERTM mice compared
to control mice calculated using Image J software(*p,0.015). Mice used
were 3–4 months of age.
doi:10.1371/journal.pone.0045261.g001
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reminiscent of the dilated lymphatics observed in human patients
with intestinal lymphangiectasia.
Intestinal lymphatics are required for normal lipid absorption,
and patients with intestinal lymphangiectasia often present with
weight loss as a result of lipid malabsorption [30]. Therefore, the
function of these vessels was evaluated by placing Calcrlfl/fl/
CAGGCre-ERTM and Calcrlfl/fl control mice on a short term
Western Diet following an overnight fast. After 1K hours of
Western Diet, the Calcrlfl/fl/CAGGCre-ERTM mice exhibited chyle-
filled mesenteric lymphatic vessels which were not visible in the
Calcrlfl/fl control mice (Figure 2H,I). Chyle-filled submucosal
lymphatic vessels were also visibly distinguishable in Calcrlfl/fl/
Figure 2. Dilated lacteals and submucosal lymphatics in Calcrlfl/fl/CAGGCre-ERTM mice and chyle-filled lymphatics after short-term
Western diet. A,B, Hematoxylin and eosin staining of mouse intestine showing normal histology in both Calcrlfl/fl(A) and Calcrlfl/fl/CAGGCre-ERTM
mice(B) (6.3x objective, scale = 500 mm). C,D,E, Lymphatic marker expression in the lacteals and submucosal lymphatic vessels in wildtype mouse.
Image was obtained from the jejunum of the intestine. Lyve-1 (C,green) and podoplanin(D,red) colocalize in the lymphatic vessels as seen in the
merged image(E) (20x objective; scale = 100 mm). F,G Lyve-1(green) and DAPI(blue) staining in Calcrlfl/fl(F) and Calcrlfl/fl/CAGGCre-ERTM (G) mice
indicating dilated lacteals and submucosal lymphatic vessels with temporal deletion of Calcrl in the jejunum of the intestine (4x objective,
scale = 500 mm). Histology and immunofluorescent images are representative from Calcrlflf/fl mice (n = 7) and Calcrlfl/fl/CAGGCre-ERTM mice (n = 6). H,I,
Chyle-filled mesenteric collecting lymphatic vessels in Calcrlfl/fl/CAGGCre-ERTM mice (I) relative to non-chyle filled vessels in control animals (H). Valves
are distinctly visible in Calcrlfl/fl/CAGGCre-ERTM mice (arrows; inset refers to enlarged image of valve; scale = 3 mm; n = 4 per genotype). Mice used
were 6–8 months of age.
doi:10.1371/journal.pone.0045261.g002
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CAGGCre-ERTM mice and contributed to the whitened appearance
of the intestine (Figure 2I), and some animals additionally
exhibited chyle leakage into the mesenteric space. Importantly,
the lymphatic valves of Calcrlfl/fl/CAGGCre-ERTM mice appeared
normal and were present at regular intervals along the mesenteric
collecting lymphatics (Figure 2I, arrows and inset). Therefore,
although the intestinal lymphatic vessels of Calcrlfl/fl/CAGGCre-
ERTM mice were present and appeared overtly normal, the
collecting vessels were significantly dysfunctional in their transport
of chyle as compared to control mice.
Reduced Body Weight and Impaired Lipid Absorption
with Protein-losing Enteropathy in Calcrlfl/fl/CAGGCre-
ERTM Mice
We next wanted to assess the impact of a longer term high fat
diet on intestinal lipid absorption in the Calcrlfl/fl/CAGGCre-ERTM
mice. There were no significant differences in body weights
between 3–4 month old, male or female Calcrlfl/fl/CAGGCre-ERTM
mice and Calcrlfl/fl control mice before the injection of tamoxifen
(Figure 3A,B). However, 3–4 months after the injection of
tamoxifen, we found that the Calcrlfl/fl/CAGGCre-ERTM mice
weighed significantly less than their control counterparts
(Figure 3A,B), indicating that the tamoxifen-induced loss of Calcrl
contributes to a failure of Calcrlfl/fl/CAGGCre-ERTM to gain weight
and thrive. The failure of Calcrlfl/fl/CAGGCre-ERTM mice to gain
weight and thrive was significantly exacerbated (Figure 3A,B) and
visibly apparent (Figure 3C) when the mice were fed a Western
Diet for 1K weeks.
Moreover, fecal acid steotcrit levels, representative of lipid
excretion levels, were significantly elevated in Calcrlfl/fl/CAGGCre-
ERTM animals maintained on a Western Diet for 1K weeks
compared to similarly fed Calcrlfl/fl control animals (Figure 3D),
demonstrating reduced lipid absorption. Consistently, fecal
pancreatic lipase levels were also increased in Calcrlfl/fl/CAGGCre-
Figure 3. Calcrlfl/fl/CAGGCre-ERTM mice exhibit reduced body weight due to impaired lipid absorption. A,B, Graphs of female(A) and
male(B) body weights before injection of tamoxifen (Pre-TAM; 3–4 months of age), after injection of tamoxifen (Post-TAM; 3–4 months after), and after
1K weeks on Western Diet (After WD). Both male and female Calcrlfl/fl/CAGGCre-ERTM mice were significantly smaller than Calcrlfl/fl mice after tamoxifen
injection and after Western Diet. C, Image of Calcrlfl/fl and Calcrlfl/fl/CAGGCre-ERTM mice after 1K weeks Western Diet. D, Acid steatocrit measurement in
fecal samples from Calcrlfl/fl and Calcrlfl/fl/CAGGCre-ERTM mice after Western Diet for 1K weeks indicating increased lipid excretion in the experimental
mice. E, Lipase measurements in fecal samples from Calcrlfl/fl and Calcrlfl/fl/CAGGCre-ERTM mice on Western Diet for 1 K weeks indicating increased fecal
lipase in experimental mice. F, Total triglyceride levels in Calcrlfl/fl and Calcrlfl/fl/CAGGCre-ERTM mice. G, Alpha-1 antitrypsin levels in fecal samples from
Calcrlfl/fl and Calcrlfl/fl/CAGGCre-ERTM mice after 1K weeks Western diet indicating lower levels in Calcrlfl/fl/CAGGCre-ERTM mice. (Integrated density values
are scaled and should be multiplied by 105). H, Image of dot blot assay for alpha-1 antitrypsin in Calcrlfl/fl and Calcrlfl/fl/CAGGCre-ERTM mice fecal samples
after Western diet (1:2000 dilution of samples). (*p,0.03;**p,0.002).
doi:10.1371/journal.pone.0045261.g003
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Figure 4. Dilated dermal lymphatic capillaries with exacerbated and prolonged edema. A,B, Images of dermal lymphatic capillaries in the
tail of Calcrlfl/fl(A) and Calcrlfl/fl/CAGGCre-ERTM (B) mice indicating increased diameter of these lymphatic vessels in Calcrlfl/fl/CAGGCre-ERTM mice
(scale = 0.5 mm). C, Graphic representation of the increase in vessel diameter in the Calcrlfl/fl/CAGGCre-ERTM mice with respect to Calcrlfl/fl mice (*p#0.05).
D, Edema formation assay using hindpaw injections of CFA (4 mg/ml on Day 0). Assessment of paw thickness over 3 weeks (n = 5 for Calcrlfl/fl and n = 4 for
Calcrlfl/fl/CAGGCre-ERTM mice) indicated enhanced and prolonged edema in Calcrlfl/fl/CAGGCre-ERTM mice relative to control mice (***p,0.05, **p,0.01,
*p,0.001). Representative images of CFA-injected hindpaws at Day 11 for Calcrlfl/fl and Calcrlfl/fl/CAGGCre-ERTM mice (scale = 3 mm). Mice used were 6–8
months of age.
doi:10.1371/journal.pone.0045261.g004
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Figure 5. Increased lymphatic vascular permeability without change to blood vascular permeability in Calcrlfl/fl/CAGGCre-ERTM mice.
A,B,C,D, In vivo lymphatic permeability assay assessing the leakage of Evan’s blue dye from the dermal lymphatic vessels in the ear. Images
represent Evan’s blue dye location directly after injection of the dye and 5 minutes post injection. There is an increase in leakage of the dye from the
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ERTM animals, likely due to the compensatory effects of pancreatic
lipase conversion of triglycerides into monoglycerides and free
fatty acids during periods of reduced lipid absorption (Figure 3E).
Importantly, levels of circulating triglycerides were unchanged in
the Calcrlfl/fl/CAGGCre-ERTM mice compared to Calcrlfl/fl control
animals (Figure 3F), indicating that overall metabolism is not
compromised in Calcrlfl/fl/CAGGCre-ERTM mice and supporting
the conclusion that their failure to gain weight is due to abnormal
lipid absorption in the intestine. Finally, fecal samples of Western
Diet-fed Calcrlfl/fl/CAGGCre-ERTM mice contained a significantly
elevated level of alpha-1 antiptrysin–a clinical diagnostic marker
for protein-losing enteropathy–compared to similarly fed Calcrlfl/fl
control mice (Figure 3G,H).
Temporal Deletion of Calcrl Results in Increased Dermal
Lymphatic Capillaries with Exacerbated and Prolonged
Edema
The dermal lymphatic capillaries of Calcrlfl/fl/CAGGCre-ERTM
mice also exhibited significant dilation and dysfunction. Specifi-
cally, intradermal injection of a large molecular weight (200 kDa)
FITC-dextran into the subdermal area of the tail tip revealed
significantly enlarged dermal capillaries in Calcrlfl/fl/CAGGCre-
ERTM mice compared to Calcrlfl/fl control mice (Figure 4A,B,C).
Despite this dermal lymphangiectasia, we noticed that at the basal
or quiescent state, Calcrlfl/fl/CAGGCre-ERTM mice did not exhibit
pronounced edema in their extremities (Figure 5F, day 0). Thus,
we injected the hindpaws of Calcrlfl/fl/CAGGCre-ERTM and Calcrlfl/fl
control mice with (CFA) in order to challenge the lymphatic
vascular system with localized edema. Both Calcrlfl/fl/CAGGCre-
ERTM mice and Calcrlfl/fl control mice exhibited a rapid and
significant increase in hindpaw thickness within 1 day of CFA
injection (Figure 4D). However, unlike the Calcrlfl/fl control mice
which immediately began to resolve their edema by day 3, the
Calcrlfl/fl/CAGGCre-ERTM mice developed exacerbated and pro-
longed edema that peaked between days 9–11, and only began to
show slight improvement after two weeks following CFA injection
(Figure 4D). These data demonstrate that the expression of Calcrl is
required for maintaining highly effective lymphatic function under
conditions of edema and inflammation.
Calcrlfl/fl/CAGGCre-ERTM Mice Exhibit Increased Lymphatic
Capillary Permeability with No Apparent Disruption of
Blood Vascular Permeability
To better evaluate the permeability of lymphatic and blood
vasculatures in Calcrlfl/fl/CAGGCre-ERTM and Calcrlfl/fl mice, we
used the small molecular weight Evan’s blue dye which can freely
penetrate in and out of dermal capillaries. Injection of 0.5% Evan’s
blue dye intradermally in the ear showed rapid uptake of the dye by
dermal lymphatics in both Calcrlfl/fl/CAGGCre-ERTM and Calcrlfl/fl
mice (Figure 5A,B). However after 5 minutes, Calcrlfl/fl/CAGGCre-
ERTM mice exhibited increased leakage of the dye from the
lymphatic vessels, as evidenced by the diffuse spreading of the dye
and poorly demarcated lymphatics throughout the ear region
compared to the Calcrlfl/fl control mice (Figure 5C,D). To determine
whether this lymphatic permeability defect was impacted or perhaps
confounded by a permeability defect in the blood vasculature, we
also measured relative blood vascular permeability in mice receiving
a venous injection of Evan’s blue dye. Absorbance readings of
Evan’s blue dye showed no statistically significant differences
between Calcrlfl/fl/CAGGCre-ERTM mice and Calcrlfl/fl control mice
for multiple tissues including liver, lung, adductor muscle, spleen,
intestine, heart and brain (Figure 5E). Based on these data, we
conclude that temporal deletion of Calcrl in adult animals results in
increased lymphatic capillary permeability with no overt or
functional changes in blood vascular permeability.
Inhibition of AM Signaling Results in Disorganization of
Lymphatic Endothelial Cell Junctions
To elucidate the molecular mechanisms contributing to the
lymphatic dysfunction in Calcrlfl/fl/CAGGCre-ERTM mice, we
evaluated VE-Cadherin expression and localization in mesenteric
lymphatic vessels of Calcrlfl/fl/CAGGCre-ERTM and Calcrlfl/fl control
mice that had been fed a high fat diet for 1K hours. VE-Cadherin
expression was visibly disrupted in lymphatic vessels of Calcrlfl/fl/
CAGGCre-ERTM mice (Figure 6B,D) compared to control mice
(Figure 6A,C). More specifically, while the relative expression
levels of VE-cadherin appeared similar between genotypes, the
VE-cadherin in mesenteric lymphatic vessels of Calcrlfl/fl/
CAGGCre-ERTM appeared as punctate lobules throughout the cells
and was not localized to well-defined cell boundaries, as seen in
the Calcrlfl/fl control mice.
To better characterize the effects of inhibiting Calcrl-mediated
signaling in cultured lymphatic endothelial cells (LECs) we used an
adrenomedullin-specific peptide inhibitor, AM22-52. As we have
previously described, treatment of LECs with AM peptide resulted
in a marked reorganization of junctional proteins, VE-Cadherin
and ZO-1, from a jagged, zipper-like configuration to a cohesive
and stabilized cell-cell barrier that is functionally associated with
reduced permeability (Figure 6E,F and [17]). In contrast,
treatment with the Calcrl antagonist, AM22-52, either alone or
in combination with AM, abolished the effects of AM peptide and
resulted in highly disorganized and jagged junctional protein
configurations (Figure 6G,H). Taken together, these results
demonstrate that in vitro and in vivo inhibition of Calcrl signaling,
either by antagonist treatment or by genetic deletion, results in a
profound loss of junctional protein organization, likely resulting in
increased permeability of lymphatic endothelial cell barriers.
Discussion
These studies demonstrate that temporal loss of murine Calcrl in
adulthood causes lymphatic insufficiency in a wide range of
organs, representing functional similarities to the sequelae
observed in patients with a variety of lymphangiectasia conditions.
Consistently, the lymphatic vessels in the eye, intestine and skin of
Calcrlfl/fl/CAGGCre-ERTM mice were dilated, had irregular junc-
tional protein organization and were dysfunctional when chal-
lenged with either fat absorption or edema and inflammation.
Taken together, these data identify an important new role for AM
signaling as a potent regulator of lymphatic vascular drainage and
permeability in adult animals.
The rapid-onset eye phenotype in Calcrlfl/fl/CAGGCre-ERTM
mice provides novel and clinically relevant insights to the potential
role of lymphatic vessels in the eye. Several recent studies have
shown that lymphatic markers are expressed in the human eye
[31,32], but it is still unclear whether and how these lymphatic
vessels contribute to fluid homeostasis of the eye. Our staining of
Calcrlfl/fl/CAGGCre-ERTM mice (B,D) relative to Calcrlfl/fl mice (A,C). Depicted are representative images from four independent experiments (mice 6–8
months of age). E, Blood vascular permeability assay indicating there is no difference in permeability between genotypes in the various tissues (n = 4
per genotype for each tissue).
doi:10.1371/journal.pone.0045261.g005
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Figure 6. Inhibition of AM signaling disrupts lymphatic endothelial cell-cell junctions. A,B,C,D, Confocal images of VE-Cadherin (red) and
Lyve-1(green) expression in mesenteric lymphatic vessels of Calcrlfl/fl (A,C) and Calcrlfl/fl/CAGGCre-ERTM mice (B,D) (scale = 10 mm). Boxed region
depicted in C and D. Junctional protein, VE-cadherin, is disorganized in Calcrlfl/fl/CAGGCre-ERTM mice relative to Calcrlfl/fl mice (representative images
from n = 4 per genotype, age 6–8 months). E,F,G,H, Lymphatic endothelial cells stained with VE-Cadherin (green), ZO-1 (red) and DAPI (blue) after
various treatments including a no treatment control (A), 10 nm AM (B), 1 mm AM22-52 (C), AM+AM22-52 (D) (arrow refers to inset region).
Disorganization of cell-cell junctions occurs with inhibitor treatment (AM22-52) as compared to AM treatment. (VE-cadherin = red, Lyve-1 = green,
DAPI = blue, 40x objective, scale = 100 mm; representative images from 3 independent experiments).
doi:10.1371/journal.pone.0045261.g006
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lymphatic markers in the eye correlates well with these previous
studies, since we showed robust LYVE-1 and podoplanin staining
in the ciliary body and distinct LYVE-1-positive lymphatic vessels
in the corneoscleral junction. Most importantly, we found that
temporal deletion of Calcrl resulted in dilated corneoscleral
lymphatic vessels that preceded and were associated with the
formation of corneal edema and inflammation. Therefore, it is
likely that appropriate fluid homeostasis and hydration of the
cornea, which is an important physiological feature to consider in
terms of dry eye disease, corneal surgeries or conjunctival
lymphangiectasia, is modulated by lymphatic vessels. Since AM
peptide can be clinically administered [33] and the Calcrl/Ramp
interface is pharmacologically tractable [34,35], the potential of
harnessing these targets for the therapeutic modulation of fluid
homeostasis in the eye may prove to be an exciting avenue.
The intestinal lymphatic phenotype of Calcrlfl/fl/CAGGCre-ERTM
mice also correlates well with the clinical presentation of intestinal
lymphangiectasia in humans. Under a short-term Western Diet,
Calcrlfl/fl/CAGGCre-ERTM mice showed signs of lymphatic insuffi-
ciency because their intestinal mesenteric lymphatic vessels failed to
transport chyle as effectively as similarly fed control mice. Because
Calcrlfl/fl/CAGGCre-ERTM mice are significantly leaner than age-
matched control mice 3–4 months post tamoxifen injection, it is
likely that the collecting mesenteric lymphatics of these animals
function at a consistently reduced capacity. In this regard, it is
important to note that weight loss is often associated with
lymphangiectasia in the form of protein-losing enteropathy [5]
and lipid malabsorption. Consistently, the Calcrlfl/fl/CAGGCre-ERTM
mice also exhibit elevated alpha-1 antitrypsin in fecal samples after
Western diet, which is indicative of protein-losing enteropathy,
similar to the clinical phenotype that is frequently observed in
humans with intestinal lymphangiectasia. While the mechanism of
lipid absorption through lymphatic lacteals is not completely
understood, it is thought to involve both active and passive transport
mechanisms through lymphatic endothelial cells [36]. Our data
demonstrate that AM signaling through Calcrl/Ramp2 is required for
normal intestinal lipid uptake and junctional protein organization in
intestinal lymphatic capillaries. Whether the maintenance of the
lymphatic permeability barrier and loss of Calcrl is connected with
the active and/or passive transport mechanism of lipid absorption
within the lacteal will be an important future area of study that may
have bearing on better understanding the functional underpinnings
of intestinal lymphangiectasia.
It is notable that lymphangiectasia is commonly associated with
limb edema. When placed under challenge, we found that the
hindpaw of Calcrlfl/fl/CAGGCre-ERTM mice had significantly exacer-
bated edema that resolved over a longer time period than similarly
challenged wildtype animals. These results correlate with the results
from the high fat diet in that the lymphatic system of the Calcrlfl/fl/
CAGGCre-ERTM mice does not respond effectively as that of control
mice to different stresses indicating that there are dysfunctional
lymphatic vessels in the Calcrlfl/fl/CAGGCre-ERTM mice.
Importantly, the Calcrlfl/fl/CAGGCre-ERTM mice do not exhibit
overt edema in the basal state and we found no significant effects of
Calcrl loss on blood vascular permeability. Studies by T. Shindo and
colleagues using Ramp2 gene targeted mice suggested that loss of
Ramp2 led to a reduction in the expression of junctional proteins and
a loss of blood vascular integrity [37]. Using an independent line of
Ramp2 gene targeted mice, we have demonstrated that Ramp22/2
mice also have arrested lymphangiogenesis [12]. Because Ramp2
associates with multiple G protein-coupled receptors beyond Calcrl,
it is likely that the expanded vascular phenotypes of Ramp22/2 mice
can be attributed to additional signaling pathways, and this notion is
further supported by the extensive endocrine phenotypes of
Ramp2+/2 mice compared to Calcrl+/2 mice [38]. Taken together,
these data continue to support a predominant and preferential role
for Calcrl in the lymphatic vasculature compared to the blood
vasculature [39], which may be partially explained by the fact that
Calcrl and Ramp2 are expressed at higher levels in lymphatic
endothelial cells compared to blood endothelial cells [18–20].
Calcrl also serves as a receptor component for the neuropeptide,
calcitonin gene related peptide (CGRP), when the receptor is
associated with RAMP1. Therefore, we cannot formally exclude the
possibility that the phenotypes from temporal loss of Calcrl are not
partially attributable to loss of CGRP signaling. For example, other
studies have indicated that adult aCGRP knockout mice fed a high fat
diet do not gain as much weight as control mice. However, in contrast
to the Calcrlfl/fl/CAGGCre-ERTM mice, the aCGRP knockout mice eat
more and have higher levels of energy expenditure compared to
controls [43]. Also, in our colony, aCGRP knockout mice and
RAMP1 knockout mice have never exhibited the visible eye phenotype
that is hallmark of the Calcrlfl/fl/CAGGCre-ERTM mice. Finally, the
aCGRP knockout mice [40–42] are not embryonic lethal and no
vascular defects have been reported in these mice. In contrast, many
similarities exist between the phenotypes of Calcrl knockout mice and
those of AM and RAMP2 knockout mice, with a primary defects in the
vasculature. Therefore, while some implication of CGRP signaling
cannot be excluded in the Calcrlfl/fl/CAGGCre-ERTM mice, the
phenotypes revealed are more consistent with a predominant
attribution to AM signaling. Nevertheless, additional characterization
of Calcrlfl/fl/CAGGCre-ERTM mice for phenotypes more closely
associated with the physiological functions of CGRP, like pain
perception, will be an interesting future direction.
Ultimately these studies indicate functional similarities between
temporal loss of Calcrl in adult mice and human lymphangiectasia, but
the mechanistic relationship remains elusive and will be an interesting
focus for future studies. The underlying cause of lymphatic insufficiency
in Calcrlfl/fl/CAGGCre-ERTM mice is likely attributable to various
mechanisms including insufficient lymph transport and disrupted
lymphatic vessel permeability. The Calcrlfl/fl/CAGGCre-ERTM mice do
not respond sufficiently to stress on the lymphatic system indicating the
lymphatic network is dysfunctional. Moreover, our permeability
findings are consistent with previous studies showing that addition of
AM both in vitro and in vivo results in decreased permeability of LECs
and lymphatic vessels through reorganization of the junctional proteins
VE-cadherin and ZO-1 [17]. In the blood vasculature, Rap1 (Ras-
related protein 1), a small GTPase, plays a predominant role in
regulating cell adhesion and cell junction organization in response to
cAMP/Epac/ERK signaling pathways [44]. Since the major down-
stream effectors of AM signaling in LECs are cAMP/Epac/ERK, it
will be interesting in future studies to determine whether similar or
identical Rap1 mechanisms contribute to the lymphatic permeability
phenotypes of Calcrlfl/fl/CAGGCre-ERTM mice.
Supporting Information
Figure S1 The acute onset eye phenotype with temporal
deletion of Calcrl is not associated with glaucoma-like
characteristics. A,B, TUNEL staining of retinal ganglion cells
(arrows) in Calcrlfl/fl (A) and Calcrlfl/fl/CAGGCre-ERTM mice (B)
(DAPI = red; TUNEL = green; scale = 100 mm) C, Tonometry
measurements of intraocular pressure in Calcrlfl/fl and Calcrlfl/fl/
CAGGCre-ERTM mice before tamoxifen injection and one month
post-injection.
(TIF)
Figure S2 Calcrl gene expression in lung and heart
tissue of Calcrlfl/fl and Calcrlfl/fl/CAGGCre-ERTM. A,
qRT-PCR quantitation of relative expression of Calcrl normalized
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to mouse elongation factor in Calcrlfl/fl and Calcrlfl/fl/CAGGCre-
ERTM non-injected control mice relative to Calcrlfl/fl/CAGGCre-
ERTM mice. There is a significant reduction in Calcrl expression in
both lung and heart tissue of Calcrlfl/fl/CAGGCre-ERTM mice
relative to control mice (*p,0.04, **p,0.02).
(TIF)
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